LT2686013T - Alergijos žemės riešutams gydymas - Google Patents
Alergijos žemės riešutams gydymasInfo
- Publication number
- LT2686013T LT2686013T LTEP12712344.6T LT12712344T LT2686013T LT 2686013 T LT2686013 T LT 2686013T LT 12712344 T LT12712344 T LT 12712344T LT 2686013 T LT2686013 T LT 2686013T
- Authority
- LT
- Lithuania
- Prior art keywords
- treatment
- peanut allergy
- allergy
- peanut
- Prior art date
Links
- 206010016946 Food allergy Diseases 0.000 title 1
- 208000008267 Peanut Hypersensitivity Diseases 0.000 title 1
- 201000010853 peanut allergy Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1104537.4A GB201104537D0 (en) | 2011-03-17 | 2011-03-17 | Treatment for peanut allergy |
| PCT/GB2012/050584 WO2012123759A1 (en) | 2011-03-17 | 2012-03-16 | Treatment for peanut allergy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2686013T true LT2686013T (lt) | 2017-07-10 |
Family
ID=44012746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP12712344.6T LT2686013T (lt) | 2011-03-17 | 2012-03-16 | Alergijos žemės riešutams gydymas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9481716B2 (lt) |
| EP (1) | EP2686013B1 (lt) |
| JP (1) | JP2014509606A (lt) |
| CN (1) | CN103596589A (lt) |
| AU (1) | AU2012228033B2 (lt) |
| CA (1) | CA2867529C (lt) |
| CY (1) | CY1119074T1 (lt) |
| DK (1) | DK2686013T3 (lt) |
| ES (1) | ES2633319T3 (lt) |
| GB (1) | GB201104537D0 (lt) |
| HR (1) | HRP20170868T1 (lt) |
| HU (1) | HUE035385T2 (lt) |
| LT (1) | LT2686013T (lt) |
| PL (1) | PL2686013T3 (lt) |
| PT (1) | PT2686013T (lt) |
| RS (1) | RS56043B1 (lt) |
| SG (2) | SG10201602013SA (lt) |
| SI (1) | SI2686013T1 (lt) |
| SM (1) | SMT201700384T1 (lt) |
| WO (1) | WO2012123759A1 (lt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2914286T3 (da) * | 2012-10-30 | 2021-11-08 | Aravax Pty Ltd | Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf |
| SI2968529T1 (sl) * | 2013-03-14 | 2021-03-31 | Aimmune Therapeutics, Inc. | Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo |
| US9492535B2 (en) | 2013-03-14 | 2016-11-15 | Aimmune Therapeutics, Inc. | Peanut formulations and uses thereof |
| RU2709771C2 (ru) * | 2013-03-15 | 2019-12-19 | Симентис Лимитед | Иммунная модуляция |
| WO2015187736A1 (en) * | 2014-06-02 | 2015-12-10 | Allergen Research Corporation | Placebo formulations and uses thereof |
| KR102541110B1 (ko) | 2014-08-25 | 2023-06-08 | 에이뮨 테라퓨틱스, 인코퍼레이티드 | 난 단백질 제형 및 이의 제조 방법 |
| FI3258962T3 (fi) * | 2015-02-20 | 2023-04-12 | Sekoitetut allergeenikoostumukset ja menetelmät niiden käyttämiseksi | |
| US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| WO2016138030A2 (en) * | 2015-02-23 | 2016-09-01 | Antera Therapeutics Inc. | Compositions and methods for tolerizing the immune system to allergens |
| US20170021010A1 (en) * | 2015-07-21 | 2017-01-26 | David Phillip ERSTEIN | Allergy preventing dosage controlled food packets |
| US10856567B2 (en) * | 2016-07-22 | 2020-12-08 | Kari Brown | Baby food products containing allergenic proteins and methods of delivering same |
| US11382934B2 (en) | 2017-07-18 | 2022-07-12 | Before Brands, Inc. | Methods for making mixed allergen compositions |
| US10603376B2 (en) | 2017-08-30 | 2020-03-31 | Roberto Garcia-Ibanez | Immunotherapy for the treatment of allergic disease |
| CA3080601A1 (en) * | 2017-11-02 | 2019-05-09 | Aimmune Therapeutics, Inc. | Methods of oral immunotherapy |
| GB201718342D0 (en) | 2017-11-06 | 2017-12-20 | Cambridge Allergy Ltd | Allergenic protein formulations for immunotherapy |
| EP3720432B1 (en) * | 2017-12-06 | 2024-11-20 | Prollergy Corporation | Composition and method for reducing allergic response |
| SG11202006732WA (en) * | 2018-01-16 | 2020-08-28 | Tel Hashomer Medical Res Infrastructure & Services Ltd | Treatment and prevention of seed allergies |
| AU2019274450A1 (en) * | 2018-05-22 | 2020-10-29 | AllerGenis LLC | Peptides and methods for detecting peanut allergies |
| CN112638413A (zh) * | 2018-07-27 | 2021-04-09 | 艾慕恩治疗公司 | 口服免疫治疗单位剂量分配系统和方法 |
| EP3836801A4 (en) * | 2018-08-16 | 2022-05-18 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy with maintenance dose |
| WO2020100024A1 (en) * | 2018-11-12 | 2020-05-22 | Murdoch Childrens Research Institute | Method and system |
| CN113891722A (zh) * | 2018-12-20 | 2022-01-04 | 爱沐疗法公司 | 用于漏服剂量的花生口服免疫疗法给药计划表 |
| CA3127337A1 (en) | 2019-01-23 | 2020-07-30 | Before Brands, Inc. | Methods for making mixed allergen compositions |
| US20220221468A1 (en) * | 2019-03-22 | 2022-07-14 | Aimmune Therapeutics, Inc. | Systemic allergic response risk assessment in peanut oral immunotherapy |
| EP3965815A4 (en) * | 2019-05-10 | 2023-05-31 | Société des Produits Nestlé S.A. | METHOD OF IMPROVING THE QUALITY OF LIFE IN A PEANUT ALLERGY PATIENT |
| WO2020237181A1 (en) * | 2019-05-23 | 2020-11-26 | Aimmune Therapeutics, Inc. | Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance |
| WO2021102186A1 (en) * | 2019-11-20 | 2021-05-27 | Aimmune Therapeutics, Inc. | Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug |
| AU2020412960A1 (en) * | 2019-12-23 | 2022-06-16 | Prota Therapeutics Pty Ltd | Allergy treatment |
| EP4081251A4 (en) * | 2019-12-23 | 2024-03-20 | Prota Therapeutics Pty Ltd | PHARMACEUTICAL COMPOSITIONS |
| WO2023200316A1 (ko) * | 2022-04-15 | 2023-10-19 | 사회복지법인 삼성생명공익재단 | 경구면역요법을 이용한 식품알레르기 치료서비스 제공방법, 이를 구현하기 위한 기록매체에 저장된 컴퓨터 프로그램 및 시스템 |
| NL2033338B1 (en) | 2022-10-17 | 2024-05-03 | Vini Mini B V | Prevention of tree nut and seed allergy in humans |
| WO2025080707A1 (en) * | 2023-10-10 | 2025-04-17 | Intrommune Therapeutics, Inc. | Methods of inducing tolerance and reducing adverse reactions to one or more food allergens |
| WO2025109005A1 (en) * | 2023-11-20 | 2025-05-30 | Cambridge Allergy Ltd. | Immunotherapy for treatment of allergy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05005528A (es) * | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
-
2011
- 2011-03-17 GB GBGB1104537.4A patent/GB201104537D0/en not_active Ceased
-
2012
- 2012-03-16 RS RS20170551A patent/RS56043B1/sr unknown
- 2012-03-16 JP JP2013558515A patent/JP2014509606A/ja active Pending
- 2012-03-16 CN CN201280022718.XA patent/CN103596589A/zh active Pending
- 2012-03-16 PL PL12712344T patent/PL2686013T3/pl unknown
- 2012-03-16 SI SI201231014T patent/SI2686013T1/sl unknown
- 2012-03-16 HR HRP20170868TT patent/HRP20170868T1/hr unknown
- 2012-03-16 LT LTEP12712344.6T patent/LT2686013T/lt unknown
- 2012-03-16 ES ES12712344.6T patent/ES2633319T3/es active Active
- 2012-03-16 EP EP12712344.6A patent/EP2686013B1/en active Active
- 2012-03-16 PT PT127123446T patent/PT2686013T/pt unknown
- 2012-03-16 DK DK12712344.6T patent/DK2686013T3/en active
- 2012-03-16 SG SG10201602013SA patent/SG10201602013SA/en unknown
- 2012-03-16 SM SM20170384T patent/SMT201700384T1/it unknown
- 2012-03-16 HU HUE12712344A patent/HUE035385T2/en unknown
- 2012-03-16 CA CA2867529A patent/CA2867529C/en active Active
- 2012-03-16 AU AU2012228033A patent/AU2012228033B2/en active Active
- 2012-03-16 WO PCT/GB2012/050584 patent/WO2012123759A1/en not_active Ceased
- 2012-03-16 US US14/005,789 patent/US9481716B2/en active Active
- 2012-03-16 SG SG2013070115A patent/SG193518A1/en unknown
-
2017
- 2017-07-12 CY CY20171100743T patent/CY1119074T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012228033A1 (en) | 2013-10-31 |
| ES2633319T3 (es) | 2017-09-20 |
| EP2686013B1 (en) | 2017-05-03 |
| SG193518A1 (en) | 2013-10-30 |
| CY1119074T1 (el) | 2018-01-10 |
| SMT201700384T1 (it) | 2017-09-07 |
| EP2686013A1 (en) | 2014-01-22 |
| CA2867529A1 (en) | 2012-09-20 |
| JP2014509606A (ja) | 2014-04-21 |
| DK2686013T3 (en) | 2017-07-10 |
| CA2867529C (en) | 2022-08-23 |
| GB201104537D0 (en) | 2011-05-04 |
| CN103596589A (zh) | 2014-02-19 |
| SG10201602013SA (en) | 2016-04-28 |
| US20140093541A1 (en) | 2014-04-03 |
| SI2686013T1 (sl) | 2017-10-30 |
| US9481716B2 (en) | 2016-11-01 |
| HRP20170868T1 (hr) | 2017-08-25 |
| PT2686013T (pt) | 2017-07-18 |
| WO2012123759A1 (en) | 2012-09-20 |
| AU2012228033B2 (en) | 2016-09-15 |
| PL2686013T3 (pl) | 2017-10-31 |
| HUE035385T2 (en) | 2018-05-02 |
| RS56043B1 (sr) | 2017-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201602013SA (en) | Treatment for peanut allergy | |
| IL227636A0 (en) | Multimetric filtering | |
| BR112013022820A2 (pt) | método de tratamento | |
| GB201119774D0 (en) | IBS treatment | |
| ZA201308117B (en) | Avian-based treatment | |
| GB201105523D0 (en) | Treatment method | |
| GB201121950D0 (en) | Treatment process | |
| GB201119171D0 (en) | Gas treatment | |
| GB201102283D0 (en) | Treatment | |
| GB2489207B (en) | Waste treatment | |
| GB201102284D0 (en) | Treatment | |
| GB201102271D0 (en) | Treatment | |
| GB201102276D0 (en) | Treatment | |
| GB201102277D0 (en) | Treatment | |
| GB201102282D0 (en) | Treatment | |
| GB201102274D0 (en) | Treatment | |
| GB201102273D0 (en) | Treatment | |
| GB201102288D0 (en) | Treatment | |
| GB201109119D0 (en) | Treatment | |
| GB201111247D0 (en) | Treatment | |
| GB201102272D0 (en) | Treatment | |
| GB201102266D0 (en) | Treatment | |
| GB201102267D0 (en) | Treatment | |
| GB201102270D0 (en) | Treatment | |
| GB201102265D0 (en) | Treatment |